American College of Allergy, Asthma & Immunology

Wyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences - Startup aims to bring a versatile, sustainable, and scalable RNA synthesis technology to market to unlock development of new RNA drugs, vaccines, and gene-editing therapies

Go to page

Superconducting Nanowires Detect Single Protein Ions - Detection efficiency 1,000 times higher than conventional ion detectors due to high sensitivity

Go to page

Labcyte Expands Presence in Chinese Market

Go to page

Nipple_shield_(jewelry)

Go to page

Alnylam Grants Integrated DNA Technologies License to Kreutzer-Limmer Patents for the RNA Interference Research Products Market

Go to page

Recovery from spinal cord injuries can be predicted

Go to page

Traffic Light in the Brain - Research group offers new insights into the roles of different subareas in the prefrontal cortex

Go to page

New drug candidates from genome sequence - As proof-of-principle, the team designs potent anti-cancer compound

Go to page

Microbes could help reduce the need for chemical fertilizers - A coating protects nitrogen-fixing bacteria: Start-up to commercialise coated bacteria for large-scale use in regenerative agriculture

Go to page

Mapping human brain development - With the help of brain organoids, ETH researchers are investigating gene networks that control the development of different brain regions

Go to page

Technology that miniaturises measuring devices

Go to page

Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU - Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care

Go to page